What does Dokter Roel Verschooten do?

Dokter Roel Verschooten is a specialist medical practice in Keerbergen. Private Limited, started on 25 October 2012, 1 establishment.

What is the address of Dokter Roel Verschooten?

The registered office of Dokter Roel Verschooten is located at Achiel Cleynhenslaan 200 D, 3140 Keerbergen.

Is Dokter Roel Verschooten still active?

Yes. According to the CBE (18 September 2026) Dokter Roel Verschooten is active, legal situation “Normale toestand”, started on 25 October 2012.

Is Dokter Roel Verschooten registered on Peppol?

Yes, Dokter Roel Verschooten is registered on the Peppol network with ID 0208:0849884405.

What is the enterprise number of Dokter Roel Verschooten?

The enterprise number of Dokter Roel Verschooten is BE0849884405.

When was Dokter Roel Verschooten founded?

Dokter Roel Verschooten was founded on 25 October 2012.

Who are the directors of Dokter Roel Verschooten?

According to the 2025 annual accounts, the directors of Dokter Roel Verschooten are: Roel Verschooten.

Is Dokter Roel Verschooten a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 October 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dokter Roel Verschooten make in 2025?

Dokter Roel Verschooten posted a profit after taxes of € 385,786 in financial year 2025.

What is the revenue of Dokter Roel Verschooten?

As a small company, Dokter Roel Verschooten is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 624,723.

Dokter Roel Verschooten (Private Limited) - Keerbergen

Dossier Dokter Roel Verschooten, printed on 18 September 2026 from databakkes.be/en/0849884405/dokter-roel-verschooten. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dokter Roel Verschooten from Keerbergen, company number BE0849884405, closed financial year 2025 with a result of € 385,786 after tax. For that financial year Dokter Roel Verschooten recorded a gross margin of € 624,723 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 381,889 to € 385,786. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2026.

What it is worth Healthy

€ 1.2 million

▼ 26% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 385,786

▲ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 535,039

▲ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 792,487 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 63,429

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 243,442

€ 23,549 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 5,357

▼ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 12,209

▼ 77% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 415,778 Gross margin 2022: € 415,778 First fiscal year in the series	€ 553,443 Gross margin 2023: € 553,443 ▲ 33% vs 2022 (€ 415,778) Favourable step	€ 574,541 Gross margin 2024: € 574,541 ▲ 4% vs 2023 (€ 553,443) Favourable step	€ 624,723 Gross margin 2025: € 624,723 ▲ 9% vs 2024 (€ 574,541) Favourable step	▲ 9%
Profit after taxes	€ 267,654 Profit after taxes 2022: € 267,654 First fiscal year in the series	€ 382,983 Profit after taxes 2023: € 382,983 ▲ 43% vs 2022 (€ 267,654) Favourable step	€ 381,889 Profit after taxes 2024: € 381,889 Unchanged (€ 382,983) Unfavourable step	€ 385,786 Profit after taxes 2025: € 385,786 ▲ 1% vs 2024 (€ 381,889) Favourable step	▲ 1%
Equity	€ 1,062,087 Equity 2022: € 1,062,087 First fiscal year in the series	€ 1,344,270 Equity 2023: € 1,344,270 ▲ 27% vs 2022 (€ 1,062,087) Favourable step	€ 1,575,327 Equity 2024: € 1,575,327 ▲ 17% vs 2023 (€ 1,344,270) Favourable step	€ 1,168,626 Equity 2025: € 1,168,626 ▼ 26% vs 2024 (€ 1,575,327) Unfavourable step	▼ 26%
Total debts	€ 134,903 Total debts 2022: € 134,903 First fiscal year in the series	€ 164,017 Total debts 2023: € 164,017 ▲ 22% vs 2022 (€ 134,903) Unfavourable step	€ 281,805 Total debts 2024: € 281,805 ▲ 72% vs 2023 (€ 164,017) Unfavourable step	€ 1,036,595 Total debts 2025: € 1,036,595 ▲ 268% vs 2024 (€ 281,805) Unfavourable step	▲ 268%
Cash	€ 849,218 Cash 2022: € 849,218 First fiscal year in the series	€ 328,147 Cash 2023: € 328,147 ▼ 61% vs 2022 (€ 849,218) Unfavourable step	€ 426,832 Cash 2024: € 426,832 ▲ 30% vs 2023 (€ 328,147) Favourable step	€ 535,039 Cash 2025: € 535,039 ▲ 25% vs 2024 (€ 426,832) Favourable step	▲ 25%
Land & buildings	-	-	-	€ 273,075 Land & buildings 2025: € 273,075 First fiscal year in the series
Retained profit	€ 1,049,587 Retained profit 2022: € 1,049,587 First fiscal year in the series	€ 1,331,770 Retained profit 2023: € 1,331,770 ▲ 27% vs 2022 (€ 1,049,587) Favourable step	€ 1,562,827 Retained profit 2024: € 1,562,827 ▲ 17% vs 2023 (€ 1,331,770) Favourable step	€ 1,156,126 Retained profit 2025: € 1,156,126 ▼ 26% vs 2024 (€ 1,562,827) Unfavourable step	▼ 26%
Dividend	€ 50,800 Dividend 2022: € 50,800 First fiscal year in the series	€ 100,800 Dividend 2023: € 100,800 ▲ 98% vs 2022 (€ 50,800) Unchanged	€ 150,833 Dividend 2024: € 150,833 ▲ 50% vs 2023 (€ 100,800) Unchanged	€ 792,487 Dividend 2025: € 792,487 ▲ € 641,654 vs 2024 (€ 150,833) Unchanged	▲ € 641,654
Bank debt	€ 4,292 Bank debt 2022: € 4,292 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 4,292) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 243,442 Bank debt 2025: € 243,442 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 1,196,990 Balance sheet total 2022: € 1,196,990 First fiscal year in the series	€ 1,508,287 Balance sheet total 2023: € 1,508,287 ▲ 26% vs 2022 (€ 1,196,990) Unchanged	€ 1,857,132 Balance sheet total 2024: € 1,857,132 ▲ 23% vs 2023 (€ 1,508,287) Unchanged	€ 2,205,221 Balance sheet total 2025: € 2,205,221 ▲ 19% vs 2024 (€ 1,857,132) Unchanged	▲ 19%

Key figures of Dokter Roel Verschooten, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dokter Roel Verschooten?

What happened at Dokter Roel Verschooten in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 4, 2026 New annual accounts for financial year 2025: profit of € 385,786 (▲ 1% vs 2024). Source: NBB ↗
Oct 25, 2012 New establishment in Keerbergen. KBO
Oct 25, 2012 Start of the company according to the CBE. KBO
2012 Roel Verschooten became a director. NBB

In short

From € 267,654 profit in 2022 to € 385,786 profit in 2025.

Paid € 639,838 in corporate taxes since 2022.

Best year ever: 2025, with € 385,786 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dokter Roel Verschooten? We notify you, reason included.

Follow Dokter Roel Verschooten

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Roel Verschooten

Dokter Roel Verschooten

Behind Dokter Roel Verschooten is Roel Verschooten.

See the full network in the app

Directors

According to the 2025 annual accounts

Roel Verschooten

Director

since 2012

Establishments

Establishment units

Physical locations of this company

Registered office

Achiel Cleynhenslaan 200 D

3140 Keerbergen

2.213.771.810

Achiel Cleynhenslaan 200D

3140 Keerbergen

Active since 25 October 2012

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0849.884.405

VAT number

BE 0849.884.405

Registered office

Achiel Cleynhenslaan 200 D, 3140 Keerbergen

Names & denominations

Dokter Roel Verschooten

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

25 October 2012

Peppol

Active · Active since 30 May 2025

Activities · NACE

Activiteiten van medisch specialisten

Overige persoonlijke diensten

View on CBE Public ↗ Annual accounts (NBB) ↗

Dokter Roel Verschooten

Financials

What happened to Dokter Roel Verschooten?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions